- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04894032
Combination of Laparoskopic Uterosacral Ligament and Round Ligament Plication, A Meshless Method in the Surgical Treatment of Pelvic Organ Prolapse.
Postoperative Results of a Meshless Method in the Surgical Treatment of Pelvic Organ Prolapse; Combination of Laparoscopic Uterosacral Ligament and Round Ligament Plication.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Following the approval of the ethics committee, Female patients admitted to Urogynecology and Gynecology Outpatient Clinic of Zeynep Kamil Gynecology and Child Diseases Education and Research Hospital with the complaint of prolapse of the genital organs, who do not respond or not willing to take conservative treatment and have Stage 2 or higher pelvic organ prolapse according to POP-Q staging system and who have completed the fertility period will be included in our study. Patients Age, gravida and parity of the patients, menopausal status, whether she is hysterectomized, the stage of prolapse according to POP-Q and other gynecological examination findings will be recorded.Patients will be asked about preoperative urinary system pathologies (voiding dysfunction, urinary incontinence, recurrent UTI) and Urodynamic examination will be done accordingly.
Prolapsus and its Impact on the quality of life will be recorded preoperatively with quality of life questionnaires.At the early postoperative period and preoperatively, the duration of the operation, blood loss during the surgery, VAS score , and the presence of complications will be recorded. Patients will be called postoperatively for control examination at the 1st month , 6th month , 1st year and subsequently annual control will be done.Objective success; Stage 1 according to POP-Q or no prolapse. Subjective success will be accepted once the patient has no prolapse-related complaints.In the postoperative period, whether there is any change in urinary system and sexual functions will be questioned with the help of questionnaires.Laparoscopic Uterosacral Ligament plication, fixation of PVC fascia and the combination with round ligament plication will be evaluated in terms of efficacy and reliability.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Sultan Seren Karakus, MD
- Phone Number: 00905355660095
- Email: serensultan@hotmail.com
Study Locations
-
-
-
Istanbul, Turkey, 34668
- Recruiting
- Zeynep Kamil Maternity and Childrens Training and Research Hospital
-
Contact:
- Sultan Seren Karakus, MD
- Phone Number: 00905355660095
- Email: serensultan@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Female patients age between 30 to 85
- Having Stage 2 or higher pelvic organ prolapse according to POP-Q staging system
- Patients who accept the surgical treatment
Exclusion Criteria:
- Patients who have a gynecological malignancy
- Pregnant patients
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
recurrent rate after a meshless method in pelvic prolapse surgery
Time Frame: Through study completion, an average of 6 months
|
Combination of Laparoskopic Uterosacral Ligament and Round Ligament plication
|
Through study completion, an average of 6 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9/2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pelvic Organ Prolapse
-
University of CalgaryAlberta Health services; Cook Group IncorporatedCompletedAnterior Pelvic Organ ProlapseCanada
-
Coloplast A/SCompletedPelvic Organ Prolapse (POP)United States
-
University of British ColumbiaCompletedPelvic Organ Prolapse, Patient EducationCanada
-
University of MelbourneCompletedVaginal Hysterectomy | Pelvic Organ Prolapse Vaginal SurgeryAustralia
-
Unity Health TorontoUnknownVoiding Dysfunction After Pelvic Organ Prolapse SurgeryCanada
-
Nykøbing Falster County HospitalZealand University Hospital; University Hospital, Gentofte, Copenhagen; Copenhagen...UnknownBenign Hysterectomy | Postoperative Pelvic Organ Prolapse | Suspension
-
Mackay Medical CollegeRecruitingPelvic Organ Prolapse | Stage III and IV High Grade Pelvic Organ ProlapseTaiwan
-
Peking Union Medical College HospitalUnknown
-
Gaziosmanpasa Research and Education HospitalRecruitingPatients With Pelvic Organ Prolapse | Pectopexy | Lateral Suspension | Pop-q | Pisq-12Turkey
-
Charles University, Czech RepublicUnknownPelvic Organ Prolapse RecurrenceCzech Republic
Clinical Trials on Combination of Laparoscopic Uterosacral Ligament and Round Ligament Plication.
-
Kaiser PermanenteMassachusetts General HospitalUnknownProlapse of Vaginal Vault After HysterectomyUnited States
-
Beaujon HospitalUnknown
-
University Hospitals Cleveland Medical CenterUniversity of Pittsburgh; The Cleveland Clinic; Duke University; Case Western Reserve... and other collaboratorsRecruitingUterine ProlapseUnited States
-
Hospital ZnojmoCompletedCruciate Ligament Rupture
-
Pierre Fabre MedicamentCompletedAtopic DermatitisEstonia, France, Lithuania, Poland, Romania
-
Lower Saxony Center for NephrologyCompletedHerpesviridae Infections | Cytomegalovirus Infection | DNA Virus Infection
-
Wroclaw Medical UniversityUnknown
-
Novartis PharmaceuticalsCompletedHereditary HemochromatosisBelgium, France, Russian Federation, Romania, Slovakia, Spain, Switzerland
-
Roche Global DevelopmentCompletedHIV Infections | Cytomegalovirus RetinitisUnited States, Canada
-
Medical University of LodzRecruiting